ACCESSION: MSBNK-SMB_Measured-HSA031P0308002
RECORD_TITLE: Annotated; N-Acetylneuraminic acid; LC-ESI-QTOF; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.24, Processed 2025.02.24, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 10.000
COMMENT: MS2_M/Z_AVERAGED_THRES 15.000
COMMENT: DATASET_FILE_NUM 59
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'HC15-neg_427': {'bp': 2276.0, 'sum': 5590.0}, 'RA4-neg_454': {'bp': 1746.0, 'sum': 4038.0}, 'HC10-neg_434': {'bp': 1550.0, 'sum': 4076.0}, 'RA6-neg_461': {'bp': 1349.0, 'sum': 4036.0}, 'RA6-neg_447': {'bp': 1261.0, 'sum': 3949.0}, 'HC21-neg_460': {'bp': 949.0, 'sum': 2193.0}, 'RA12-neg_431': {'bp': 865.0, 'sum': 2695.0}, 'HC13-neg_444': {'bp': 863.0, 'sum': 2231.0}, 'RA24-neg_461': {'bp': 847.0, 'sum': 1968.0}, 'QC4-neg_488': {'bp': 810.0, 'sum': 1897.0}, 'RA17-neg_428': {'bp': 625.0, 'sum': 1848.0}, 'RA19-neg_446': {'bp': 584.0, 'sum': 1398.0}, 'RA9-neg_454': {'bp': 581.0, 'sum': 1091.0}, 'RA13-neg_467': {'bp': 465.0, 'sum': 770.0}, 'RA26-neg_490': {'bp': 454.0, 'sum': 810.0}, 'RA21-neg_462': {'bp': 397.0, 'sum': 652.0}, 'RA26-neg_464': {'bp': 322.0, 'sum': 526.0}, 'HC18-neg_490': {'bp': 269.0, 'sum': 626.0}}
COMMENT: RETENTION_TIME_STDEV 0.014
COMMENT: PRECURSOR_M/Z_RAW 308.099696
COMMENT: PRECURSOR_M/Z_STDEV 0.000711
COMMENT: PRECURSOR_IN_MS1 mz 308.098278; int 443.689; delta(ppm) -3.657421
COMMENT: PROPOSED_CHARGE_STATE -1; mz 309.100489; int 42.408; cor 0.964
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 5.691; C12H15N5O5; [M-H]1; delta(ppm) -5.690613
COMMENT: PROPOSED_MF SevenGoldenRules 1.362; C11H19NO9; [M-H]1; delta(ppm) -1.361994
COMMENT: PROPOSED_MF SevenGoldenRules 2.624; C15H21NO2P2; [M-H]1; delta(ppm) 2.623699
COMMENT: PROPOSED_MF SevenGoldenRules 7.968; C17H16N3OP; [M-H]1; delta(ppm) 7.968152
COMMENT: PROPOSED_MF MS-FINDER 4.536; C11H19NO9; [M-H]-; delta(ppm) -1.365730
COMMENT: PROPOSED_MF MS-FINDER 3.921; C12H15N5O5; [M-H]-; delta(ppm) -5.706567
COMMENT: PROPOSED_MF MS-FINDER 3.692; C15H19NO4S; [M-H]-; delta(ppm) 6.755456
COMMENT: PROPOSED_MF MS-FINDER 3.179; C5H20N5O8P; [M-H]-; delta(ppm) 1.988918
COMMENT: PROPOSED_MF MS-FINDER 3.172; C6H16N9O4P; [M-H]-; delta(ppm) -2.351949
COMMENT: PROPOSED_MF MS-FINDER 3.160; C6H24N5O3PS2; [M-H]-; delta(ppm) -0.831671
COMMENT: PROPOSED_MF MS-FINDER 3.148; C8H11N11O3; [M-H]-; delta(ppm) 3.009223
COMMENT: PROPOSED_MF MS-FINDER 3.086; C7H25N3O4P2S; [M-H]-; delta(ppm) 4.748910
COMMENT: PROPOSED_MF MS-FINDER 3.052; C12H23NO4S2; [M-H]-; delta(ppm) -4.186300
COMMENT: PROPOSED_MF MS-FINDER 2.964; C7H15N7O7; [M-H]-; delta(ppm) 7.350136
COMMENT: PROPOSED_MF MS-FINDER 2.832; C7H23N3O6S2; [M-H]-; delta(ppm) 8.870443
COMMENT: PROPOSED_MF MS-FINDER 2.752; C16H15N5S; [M-H]-; delta(ppm) 2.414548
COMMENT: PROPOSED_MF MS-FINDER 2.524; C8H19N7O2S2; [M-H]-; delta(ppm) 4.529517
COMMENT: PROPOSED_MF MS-FINDER 2.346; C8H27N3OS4; [M-H]-; delta(ppm) 6.049815
COMMENT: PROPOSED_MF MS-FINDER 1.950; C13H19N5S2; [M-H]-; delta(ppm) -8.527113
COMMENT: PROPOSED_MF SIRIUS5_Sirius 14.456; C11H19NO9; [M-H]-; delta(ppm) -1.365730
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.922; C12H15N5O5; [M-H]-; delta(ppm) -5.706567
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.317; C15H19NO4S; [M-H]-; delta(ppm) 6.755456
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.591; C12H23NO4S2; [M-H]-; delta(ppm) -4.186300
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C16H15N5S; [M-H]-; delta(ppm) 2.414548
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C18H16ClN3; [M-H]-; delta(ppm) -72261.379739
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H19NO9; [M-H]-; delta(ppm) -1.365730
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.312; C11H19NO9; [M-H]-; delta(ppm) -1.365730
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.624; C12H15N5O5; [M-H]-; delta(ppm) -5.706567
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.901; C15H19NO4S; [M-H]-; delta(ppm) 6.755456
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.305; C7H15N7O7; [M-H]-; delta(ppm) 7.350136
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.175; C12H23NO4S2; [M-H]-; delta(ppm) -4.186300
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.075; C11H15B2NO8; [M-H]-; delta(ppm) 69516.509431
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.778; C10H23NO6Si2; [M-H]-; delta(ppm) -171875.107228
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.964; C9H16FN5O6; [M-H]-; delta(ppm) -9.415243
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.828; C11H19N5O2Si2; [M-H]-; delta(ppm) -171878.084145
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.824; C9H18F3NO7; [M-H]-; delta(ppm) 6.570986
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H19NO9; [M-H]-; delta(ppm) -1.365730
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 11.000; SQVRNKJHWKZAKO-PFQGKNLYSA-N; C11H19NO9; N-Acetylneuraminic acid - 40.0 eV
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 9.000; SQVRNKJHWKZAKO-UHFFFAOYSA-N; C11H19NO9; Massbank:PR100695 N-Acetylneuraminic acidNANNANANeu5AcLactaminic acidSialic acid5-Acetamido-3,5-dideoxy-D-glycero-D-galactononulosonic acidNeuraminic acid N-acetateAceneuramic Acid5-Acetylamino-3,5-dideoxy-D-g
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 6.000; SQVRNKJHWKZAKO-LUWBGTNYSA-N; C11H19NO9; N-ACETYLNEURAMINATE
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.404; SQVRNKJHWKZAKO-QHCAUNKLNA-N; [M-H]-; CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.381; BJOZNDRNJJZHPZ-LUWBGTNYSA-N; [M-H]-; CC(=O)OC[C@@H](O)[C@@H](O)[C@@H]1OC(O)(C[C@H](O)[C@H]1N)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.243; NQJPQZNYMMPJQU-ZSAGQLGGSA-N; [M-H]-; C(CC(=O)O)C(C(=O)OCC(C(C(C(C=O)O)O)O)O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.243; KBGAYAKRZNYFFG-FRORGZLBNA-N; [M-H]-; CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.154; GQVIEINXGNUFMK-PFQGKNLYSA-N; [M-H]-; CC(=O)OC1(CC(C(C(O1)C(C(CO)O)O)N)O)C(=O)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.223; SQVRNKJHWKZAKO-QHCAUNKLNA-N; [M-H]-; N-Acetylneuraminic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.527; KBGAYAKRZNYFFG-FRORGZLBNA-N; [M-H]-; N-Acetylneuraminic acid;5-N-Acetyl-D-neuraminic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.372; BJOZNDRNJJZHPZ-LUWBGTNYSA-N; [M-H]-; 9-O-acetylneuraminic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.201; GQVIEINXGNUFMK-PFQGKNLYSA-N; [M-H]-; (2R,4S,5R,6R)-2-acetyloxy-5-amino-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.905; NQJPQZNYMMPJQU-ZSAGQLGGSA-N; [M-H]-; (4S)-4-amino-5-oxo-5-[(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexoxy]pentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.696; DMUSQTJZYXWEJL-ZJTYPKPZNA-N; [M-H]-; UNPD141485
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.286; VBHLKZHSCMQLTI-UHFFFAOYSA-N; [M-H]-; 2-[(2-acetamido-6,9-dihydro-6-oxo-1H-purin-9-yl]methoxy]ethyl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.276; RMIAANGDAQJRIT-BBFCGAQYNA-N; [M-H]-; UNPD110779
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.274; VMHCBARXJWMNTB-MDZRLDGVNA-N; [M-H]-; UNPD149973
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.065; OBZJZDHRXBKKTJ-JTFADIMSSA-N; [M-H]-; sangivamycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.762; SJBOYFXLWONEHK-UHFFFAOYSA-N; [M-H]-; 2-[(2-acetamido-6-oxo-6,7-dihydro-1H-purin-7-yl)methoxy]ethyl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.453; ZVGACXHTMFKLII-UHFFFAOYSA-N; [M-H]-; 2-[2-(2,3-dihydro-1-benzofuran-5-yl)acetamido]-4-(methylsulfanyl)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OBZJZDHRXBKKTJ-JTFADIMSSA-N; [M-H]-; sangivamycin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SQVRNKJHWKZAKO-QHCAUNKLNA-N; [M-H]-; N-Acetylneuraminic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.985; SJBOYFXLWONEHK-UHFFFAOYSA-N; [M-H]-; 2-[(2-acetamido-6-oxo-6,7-dihydro-1H-purin-7-yl)methoxy]ethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.982; KBGAYAKRZNYFFG-FRORGZLBNA-N; [M-H]-; N-Acetylneuraminic acid;5-N-Acetyl-D-neuraminic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; VMHCBARXJWMNTB-MDZRLDGVNA-N; [M-H]-; UNPD149973
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.922; RMIAANGDAQJRIT-BBFCGAQYNA-N; [M-H]-; UNPD110779
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; DMUSQTJZYXWEJL-ZJTYPKPZNA-N; [M-H]-; UNPD141485
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; NQJPQZNYMMPJQU-ZSAGQLGGSA-N; [M-H]-; (4S)-4-amino-5-oxo-5-[(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexoxy]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.726; GQVIEINXGNUFMK-PFQGKNLYSA-N; [M-H]-; (2R,4S,5R,6R)-2-acetyloxy-5-amino-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.542; VBHLKZHSCMQLTI-UHFFFAOYSA-N; [M-H]-; 2-[(2-acetamido-6,9-dihydro-6-oxo-1H-purin-9-yl]methoxy]ethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.366; BJOZNDRNJJZHPZ-LUWBGTNYSA-N; [M-H]-; 9-O-acetylneuraminic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; SQVRNKJHWKZAKO-PFQGKNLYSA-N; [M-H]-; (2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.948; OBZJZDHRXBKKTJ-JTFADIMSSA-N; [M-H]-; 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.285; KBGAYAKRZNYFFG-BOHATCBPSA-N; [M-H]-; (4S,5R,6R,7S,8R)-5-acetamido-4,6,7,8,9-pentahydroxy-2-oxononanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; SJFUROMOGYRUFT-YUMQZZPRSA-N; [M-H]-; (2S)-3-(1H-imidazol-5-yl)-2-[[(4S)-1-methyl-2,6-dioxo-1,3-diazinane-4-carbonyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.205; IHTXJAFDKUQWOX-MCHASIABSA-N; [M-H]-; ethyl (2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.988; JEYXXVGCDYHLSB-OXGAQCCNSA-N; [M-H]-; (2S)-2-amino-5-oxo-5-[(2R,3S,4R,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]oxypentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; PUFNBARRTADWAC-AJGMQJJTSA-N; [M-H]-; (2S)-2-[[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; LBTJHRMZWNUCLH-OOQXDQRYSA-N; [M-H]-; (6E)-6-[(E)-[(Z)-2-acetyl-3-hydroxybut-2-enylidene]hydrazinylidene]-1,3-dimethyl-5-nitroso-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; OQWIKYXFAZAALW-FMDYKLJDSA-N; [M-H]-; (2S)-2-amino-5-oxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; VBHLKZHSCMQLTI-UHFFFAOYSA-N; [M-H]-; 2-[(2-acetamido-6-oxo-1H-purin-9-yl)methoxy]ethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.794; RHYOFQJYHNHREU-VISRLPHGSA-N; [M-H]-; (2S)-2-[[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylamino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.619; BJOZNDRNJJZHPZ-LUWBGTNYSA-N; [M-H]-; (4S,5R,6R)-6-[(1R,2R)-3-acetyloxy-1,2-dihydroxypropyl]-5-amino-2,4-dihydroxyoxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -6.855; SQVRNKJHWKZAKO; [M-H]-; sialate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -81.662; KBGAYAKRZNYFFG; [M-H]-; N-Acetylneuraminic acid-6-14C
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.657; DOOQNSKOYBZVQO; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.649; BJOZNDRNJJZHPZ; [M-H]-; O-Acetylneuraminic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.763; CLMZMILVSHKNLI; [M-H]-; 2-[(2S,3R,4R,5S,6R)-2,5-dihydroxy-3-[(2-hydroxyacetyl)amino]-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.416; PVOFHMJNZUCTDT; [M-H]-; 2-[3-[carboxy(methyl)amino]-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.397; SQVRNKJHWKZAKO; [M-H]-; sialate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -9.481; SQVRNKJHWKZAKO; [M-H]-; Neuac
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -94.005; BJOZNDRNJJZHPZ; [M-H]-; 6-[3-(acetyloxy)-1,2-dihydroxypropyl]-5-amino-2,4-dihydroxyoxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -104.399; KBGAYAKRZNYFFG; [M-H]-; N-Acetylneuraminic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.398; GQVIEINXGNUFMK; [M-H]-; (4S,5R,6R)-2-acetyloxy-5-amino-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.454; DOOQNSKOYBZVQO; [M-H]-; N-[(3S,5S,6R,7R)-2,2,5-trihydroxy-7-[(1R,2R)-1,2,3-trihydroxypropyl]-1,8-dioxaspiro[2.5]octan-6-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.479; CLMZMILVSHKNLI; [M-H]-; 2-[(3R,4R,5S,6R)-2,5-dihydroxy-3-[(2-hydroxyacetyl)amino]-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.001; NQJPQZNYMMPJQU; [M-H]-; 4-Amino-5-oxo-5-(2,3,4,5-tetrahydroxy-6-oxohexoxy)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.110; PUFNBARRTADWAC; [M-H]-; 2-[[(5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -257.253; PVOFHMJNZUCTDT; [M-H]-; N-Carboxy-N-methyl-muramic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.600; SQVRNKJHWKZAKO; [M-H]-; Neuac
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match N-Acetylneuraminic acid, SQVRNKJHWKZAKO-PFQGKNLYSA-N; Matching to 11 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000230;HMDB0000773;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C11H19NO9
CH$EXACT_MASS: 309.105981
CH$SMILES: CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O
CH$IUPAC: InChI=1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11-/m0/s1
CH$NAME: N-Acetylneuraminate
CH$NAME: N-Acetylneuraminic acid
CH$NAME: (2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
CH$LINK: INCHIKEY SQVRNKJHWKZAKO-PFQGKNLYSA-N
CH$LINK: PUBCHEM CID:445063
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY -30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.5 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 10.00; MS2(ppm) 15.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min, 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.859
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 308.098284
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9100000000-75fd2e3643d88d7939c0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  87.0089784 999.0000 87.008597 5.5282 0.00 1.0000 18 f{C6H1N1}/-28.38ppm,p-C5H17O9
  98.0615661 380.4167 98.061175 12.1148 94.65 0.9268 18 f{C5H8N1O1}/4.37ppm,p-C6H10O8
  170.0466995 195.1953 170.046586 12.4613 73.30 0.8201 18 f{C7H8N1O4}/4.81ppm,p-C4H10O5
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  87.008978 999.00 999
  98.061566 380.42 380
  170.046700 195.20 195
//
